ArticleFrontiers in physiology2026
Pannexin 3-mediated adenosine triphosphate release from pre-osteoblasts promotes osteoblast differentiation through P2X4 receptor activation.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increased pre-osteoblast cell density within bone resorption areas is a key factor in promoting osteoblast differentiation; however, the molecular mechanisms underlying this process remain poorly understood. In this study, we investigated the role of ATP release and purinergic receptor P2X4 signaling in osteoblast differentiation using the murine pre-osteoblastic cell line MC3T3-E1. Under high cell density conditions, which were essential for the induction of osteoblast differentiation, we observed a significant accumulation of extracellular ATP released via the hemichannel Pannexin 3 (Panx3). This ATP accumulation subsequently activated the P2X4. Pharmacological inhibition and siRNA-mediated knockdown Panx3 markedly reduced extracellular ATP levels and decreased expression and activity of alkaline phosphatase (ALP), an osteoblast differentiation marker. Similarly, pharmacological inhibition and siRNA-mediated knockdown of P2X4 suppressed ALP expression and activity. Functional analyses using calcium imaging and whole-cell patch-clamp recording revealed that P2X4 activity was enhanced during osteoblast differentiation. Notably, this functional upregulation correlated with enhanced localization of P2X4 to the plasma membrane. Moreover, pharmacological inhibition of Panx3 or P2X4 impaired the endochondral ossification of isolated mouse metatarsal bone. These findings suggest that Panx3-mediated ATP release and the subsequent activation of P2X4 signaling constitute a crucial pathway linking cell density to osteoblast differentiation. Our study provides new insights into the purinergic signaling mechanisms underlying bone formation and identifies potential molecular targets for promoting osteogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.